SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-026394
Filing Date
2020-05-20
Accepted
2020-05-20 16:31:28
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q oric-10q_20200331.htm 10-Q 1850296
2 EX-31.1 oric-ex311_228.htm EX-31.1 18910
3 EX-31.2 oric-ex312_227.htm EX-31.2 18896
4 EX-32.1 oric-ex321_226.htm EX-32.1 9546
5 EX-32.2 oric-ex322_225.htm EX-32.2 9532
  Complete submission text file 0001564590-20-026394.txt   4834418

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oric-20200331.xml EX-101.INS 749189
7 XBRL TAXONOMY EXTENSION SCHEMA oric-20200331.xsd EX-101.SCH 36603
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oric-20200331_cal.xml EX-101.CAL 29530
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oric-20200331_def.xml EX-101.DEF 113635
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE oric-20200331_lab.xml EX-101.LAB 273880
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oric-20200331_pre.xml EX-101.PRE 226825
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39269 | Film No.: 20898516
SIC: 2834 Pharmaceutical Preparations